Table 1.
Chr | Start | End | Credible set ID | Credible set size | Total PIP | N of significant variantsa | SNP with maximum PIP | Maximum PIP | A1 | Effect size | A1 Freq | Marginal P value | Gene | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2 | 161,721,597 | 162,351,261 | 1 | 6 | 0.96 | 6 | rs10930013 | 0.26 | A | −0.021 | 0.42 | 7.80 × 10−10 | TANK | Intron |
4 | 180,613,679 | 181,136,169 | 1 | 4 | 0.95 | 4 | rs2871133 | 0.36 | C | −0.020 | 0.53 | 3.54 × 10−9 | NA | NA |
5 | 93,838,858 | 94,392,030 | 1 | 20 | 0.95 | 19 | rs255347 | 0.11 | T | 0.022 | 0.73 | 5.70 × 10−9 | MCTP1 | Intron |
5 | 106,947,725 | 107,455,182 | 1 | 2 | 0.96 | 2 | rs7708343 | 0.62 | A | −0.021 | 0.32 | 4.46 × 10−9 | FBXL17 | Intron |
6 | 27,515,505 | 29,611,229 | 1 | 13 | 0.95 | 3 | rs9461540 | 0.47 | G | −0.027 | 0.17 | 6.19 × 10−10 | GABBR1 | Upstream gene |
6 | 27,515,505 | 29,611,229 | 2 | 6 | 0.96 | 6 | rs16893804 | 0.40 | G | −0.028 | 0.22 | 5.62 × 10−12 | NA | NA |
10 | 103,385,878 | 104,057,295 | 1 | 27 | 0.96 | 18 | rs11191157 | 0.60 | A | −0.023 | 0.22 | 2.34 × 10−8 | C10orf76 | Intron |
17 | 42,899,988 | 43,438,117 | 1 | 10 | 0.95 | 10 | rs12936234 | 0.20 | C | 0.020 | 0.47 | 4.28 × 10−9 | NMT1 | Intron |
Abbreviations: A1 Freq, frequency of A1; A1, effect allele; Chr, chromosome; N, number; NA, not available. Gene symbols are italicized.
aNumber of genome-wide significant variants with P value of a two-sided test <5 × 10−8.
Base pair position is based on the human genome assembly GRCh37 (hg19).
‘Credible set ID’: the ID of credible sets used to identify different credible sets in the same region.
‘Gene’: the genes affected by the variant using the Variant Effect Predictor tool.
‘Annotation’: the consequence of variants on the protein sequence using the Variant Effect Predictor tool.